A detailed history of Atom Investors LP transactions in Morphic Holding, Inc. stock. As of the latest transaction made, Atom Investors LP holds 66,628 shares of MORF stock, worth $3.8 Million. This represents 0.23% of its overall portfolio holdings.

Number of Shares
66,628
Previous 86,630 23.09%
Holding current value
$3.8 Million
Previous $3.05 Million 25.55%
% of portfolio
0.23%
Previous 0.39%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$26.12 - $34.07 $522,452 - $681,468
-20,002 Reduced 23.09%
66,628 $2.27 Million
Q1 2024

May 15, 2024

BUY
$26.64 - $40.31 $344,268 - $520,926
12,923 Added 17.53%
86,630 $3.05 Million
Q4 2023

Feb 14, 2024

BUY
$19.95 - $31.0 $551,477 - $856,933
27,643 Added 60.01%
73,707 $2.13 Million
Q3 2023

Nov 14, 2023

BUY
$21.33 - $59.42 $982,545 - $2.74 Million
46,064 New
46,064 $1.06 Million
Q2 2022

Aug 15, 2022

SELL
$19.74 - $43.01 $41,473 - $90,364
-2,101 Reduced 14.98%
11,925 $259,000
Q1 2022

May 16, 2022

SELL
$36.25 - $52.02 $26,100 - $37,454
-720 Reduced 4.88%
14,026 $563,000
Q4 2021

Feb 14, 2022

BUY
$43.27 - $65.72 $638,059 - $969,107
14,746 New
14,746 $699,000

Others Institutions Holding MORF

About Morphic Holding, Inc.


  • Ticker MORF
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,477,100
  • Market Cap $2.19B
  • Description
  • Morphic Holding, Inc., a biopharmaceutical company, discovers and develops oral small-molecule integrin therapeutics for the treatment of autoimmune, cardiovascular, metabolic diseases, as well as fibrosis and cancer. Its lead product candidates are MORF-057, an a4ß7-specific integrin inhibitor affecting inflammation that is in Phase 1 clinical ...
More about MORF
Track This Portfolio

Track Atom Investors LP Portfolio

Follow Atom Investors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Atom Investors LP, based on Form 13F filings with the SEC.

News

Stay updated on Atom Investors LP with notifications on news.